Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Ratio
|
Ratios
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Per share ratios | |||||
| Adjusted EPS (Rs) | 3.11 | 4.79 | 3.09 | 2.46 | -7.94 |
| Adjusted cash EPS (Rs) | 5.22 | 7.05 | 5.41 | 4.36 | 5.87 |
| Reported EPS (Rs) | 3.11 | 4.79 | 2.18 | 2.46 | -106.54 |
| Reported cash EPS (Rs) | 5.22 | 7.05 | 4.50 | 4.36 | -92.73 |
| Dividend per share | - | - | - | - | - |
| Operating profit per share (Rs) | 4.70 | 6.64 | 4.86 | 4.35 | 5.19 |
| Book value (excl rev res) per share EPS (Rs) | 34.17 | 31.05 | 26.58 | 24.00 | -18.64 |
| Book value (incl rev res) per share EPS (Rs) | 34.17 | 31.05 | 26.58 | 24.00 | -18.64 |
| Net operating income per share EPS (Rs) | 64.45 | 48.76 | 35.99 | 30.11 | 179.54 |
| Free reserves per share EPS (Rs) | - | - | - | - | - |
| Profitability ratios | |||||
| Operating margin (%) | 7.28 | 13.62 | 13.49 | 14.45 | 2.89 |
| Gross profit margin (%) | 4.01 | 8.99 | 7.04 | 8.17 | -4.79 |
| Net profit margin (%) | 4.81 | 9.82 | 6.05 | 8.18 | -59.34 |
| Adjusted cash margin (%) | 7.91 | 14.05 | 14.67 | 14.31 | 3.24 |
| Adjusted return on net worth (%) | 9.08 | 15.43 | 11.62 | 10.26 | - |
| Reported return on net worth (%) | 9.08 | 15.43 | 8.19 | 10.26 | - |
| Return on long term funds (%) | 10.52 | 16.67 | 11.44 | 11.08 | - |
| Leverage ratios | |||||
| Long term debt / Equity | 0.13 | 0.11 | 0.12 | 0.04 | - |
| Total debt/equity | 0.30 | 0.31 | 0.12 | 0.04 | - |
| Owners fund as % of total source | 76.82 | 76.21 | 88.84 | 95.78 | - |
| Fixed assets turnover ratio | 1.51 | 1.38 | 1.31 | 1.26 | 0.70 |
| Liquidity ratios | |||||
| Current ratio | 2.24 | 2.65 | 2.64 | 1.83 | 2.10 |
| Current ratio (inc. st loans) | 1.37 | 1.41 | 2.64 | 1.83 | 2.10 |
| Quick ratio | 1.54 | 1.98 | 1.60 | 1.26 | 1.43 |
| Inventory turnover ratio | 1.45 | 1.20 | 1.20 | 1.20 | -30.49 |
| Payout ratios | |||||
| Dividend payout ratio (net profit) | - | - | - | - | - |
| Dividend payout ratio (cash profit) | - | - | - | - | - |
| Earning retention ratio | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cash earnings retention ratio | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Coverage ratios | |||||
| Adjusted cash flow time total debt | 1.98 | 1.37 | 0.61 | 0.24 | 2.17 |
| Financial charges coverage ratio | 6.39 | 9.32 | 17.13 | 14.89 | 15.54 |
| Fin. charges cov.ratio (post tax) | 6.39 | 9.18 | 14.41 | 14.89 | -228.71 |
| Component ratios | |||||
| Material cost component (% earnings) | 60.91 | 57.69 | 50.10 | 49.10 | 55.68 |
| Selling cost Component | 0.30 | - | 0.16 | 0.01 | 0.02 |
| Exports as percent of total sales | 67.60 | 76.73 | 64.32 | 48.77 | 0.79 |
| Import comp. in raw mat. consumed | - | - | - | - | - |
| Long term assets / total Assets | 0.35 | 0.32 | 0.43 | 0.42 | 0.49 |
| Bonus component in equity capital (%) | 2.29 | 2.29 | 2.29 | 2.29 | 22.94 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis